MacroGenics Shares TAMARACK Study Data On Vobra Duo In mCRPC At ESMO
15 Sep 2024 //
GLOBENEWSWIRE
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
08 Sep 2024 //
GLOBENEWSWIRE
MacroGenics Provides Vobramitamab Duocarmazine Update
30 Jul 2024 //
GLOBENEWSWIRE
MacroGenics` stock crashes after 5 deaths in ADC trial
11 May 2024 //
FIERCE PHARMA
Byondis ESMO Presentation Confirms ADC Trastuzumab Duocarmazine is Superior
19 Sep 2021 //
PRNEWSWIRE